|
|
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
100 Clinical Results associated with CACNA1G-AS1 x BCMA x CD3
100 Translational Medicine associated with CACNA1G-AS1 x BCMA x CD3
0 Patents (Medical) associated with CACNA1G-AS1 x BCMA x CD3